Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
60.23
+1.81 (+3.10%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
43
44
Next >
Dexcom Reports Second Quarter 2023 Financial Results
July 27, 2023
From
DexCom, Inc.
Via
Business Wire
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $75,000 Today
↗
July 26, 2023
Via
Benzinga
Top Picks: 3 Stocks That (Almost) All Analysts Agree On
↗
July 20, 2023
While you shouldn’t rely on the word of analysts, sometimes they are the best stocks to buy for the long haul.
Via
InvestorPlace
Looking At DexCom's Recent Unusual Options Activity
↗
July 19, 2023
Via
Benzinga
Elliott Wave Technical Analysis: DexCom Inc. - Wednesday, July 19
↗
July 19, 2023
Looking for longs on the pullback in wave iv.
Via
Talk Markets
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
↗
July 07, 2023
Via
Benzinga
2 Growth Stocks That Could Double in 5 Years
↗
July 07, 2023
They could deliver excellent returns well beyond that.
Via
The Motley Fool
A Look Into DexCom Inc's Price Over Earnings
↗
July 05, 2023
Via
Benzinga
Peering Into DexCom's Recent Short Interest
↗
June 29, 2023
Via
Benzinga
Wall Street Believes These High-Profile Stock-Split Stocks Can Lose Up to 91% of Their Value
↗
July 19, 2023
The low-water price targets provided by select analysts and Wall Street institutions suggest these widely owned stock-split stocks could plunge.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
↗
July 12, 2023
Via
Benzinga
Nvidia And This AI Stock Lead 5 Names Near Buy Points
↗
July 08, 2023
Nvidia has soared this year. Now its tight range has created a new buy point.
Via
Investor's Business Daily
Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time
July 06, 2023
From
DexCom, Inc.
Via
Business Wire
DexCom Unusual Options Activity For June 26
↗
June 26, 2023
Via
Benzinga
Where DexCom Stands With Analysts
↗
June 26, 2023
Via
Benzinga
Just 8 S&P 500 Stocks Make The Cut In Goldman's 'Rule Of 10' Screens
↗
July 05, 2023
This elite eight meet long-term growth criteria for sales and earnings.
Via
Investor's Business Daily
Dexcom G7 Continuous Glucose Monitoring System Gets Regulatory Nod From Health Canada
↗
July 05, 2023
DexCom, Inc.'s (NASDAQ: DXCM) next-generation
Via
Benzinga
1 Stock-Split Stock to Buy Hand Over Fist in July and 1 to Avoid Like the Plague
↗
July 05, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage, there's one phenomenal value and another top performer that's arguably never been this pricey.
Via
The Motley Fool
Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians
July 04, 2023
From
Dexcom, Inc.
Via
Business Wire
DexCom Revises 2025 Outlook, Announces New Product For Diabetics
↗
June 26, 2023
DexCom Inc (NASDAQ: DXCM) disclosed the 2025 financial targets revision at
Via
Benzinga
DexCom Unusual Options Activity
↗
June 23, 2023
Via
Benzinga
Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers
↗
July 03, 2023
Via
Benzinga
Friday's ETF Winners And Losers: Large-Cap Fund Flows - VOO and SPY Add More Than $1.5 Billion Each
↗
June 30, 2023
We performed a screening of large-cap ETFs - defined as having Assets Under Management (AUM) over $10 billion - to determine what funds had the largest change in net assets on the week, according to...
Via
Benzinga
Elliott Wave Technical Analysis: DexCom Inc. - Thursday, June 29
↗
June 29, 2023
Looking for upside into wave {iii} as long as we don’t break the bottom of wave {ii}.
Via
Talk Markets
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $74,000 Today
↗
June 21, 2023
Via
Benzinga
Elliott Wave Technical Analysis: DexCom Inc, June 20
↗
June 20, 2023
Looking for a correction in wave (ii) as we seem to be extending higher into wave {iii}. We successfully broke the previous top of wave {i} to confirm further upside.
Via
Talk Markets
Dexcom, A Top 2% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market
↗
June 23, 2023
The company makes continuous glucose monitors for patients with diabetes.
Via
Investor's Business Daily
Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More
June 23, 2023
From
Dexcom, Inc.
Via
Business Wire
Dexcom Updates Long-Range Financial Targets
June 23, 2023
From
DexCom, Inc.
Via
Business Wire
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
June 21, 2023
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next.
Via
MarketBeat
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
43
44
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today